New: NCI-funded clinical trial search
Mednet Logo
CommunityEndocrinology

Endocrinology

Physician discussions on diabetes management, thyroid disorders, hormonal imbalances, and metabolic conditions.

Recent Discussions

What is your approach to patients who insist on testosterone replacement therapy despite normal testosterone levels on repeated labs?

1 Answers

Mednet MemberInvited Expert
Primary Care · University of Iowa Hospitals and Clinics

I explain that with a normal testosterone level there is no indication for testosterone replacement. Hormone replacement is always about evaluating risks and benefits. With a normal testosterone level the risks outweigh the benefit. I offer to evaluate causes for patient’s symptoms such as sleep apn...

Will you give a trial of tirzepatide in patients with PsA and obesity who have a partial response to bDMARD rather than switching their immunosuppressive regimen?

3 Answers

Mednet MemberInvited Expert
Rheumatology · Northwestern University Feinberg School of Medicine

I don't believe the data on the magnitude of the benefit of GLP-1 agonists in arthritis symptoms is sufficient to suggest that adding one of these agents would be preferable to changing DMARDs in a patient with inadequate response.

How do you counsel patients on the use of peptides like tesamorelin for weight management?

1 Answers

Mednet MemberInvited Expert
Endocrinology · Medical University of South Carolina College of Medicine

There is little to no efficacy or safety data for these peptides. As such, I do not recommend these to my patients and, in fact, try to persuade patients who are interested in them or are taking them not to take them. We need more research!

About Mednet

A community where doctors find answers to medicine's toughest questions.

  • Verified, credentialed physicians
  • 45,000+ members across 24 specialties
  • Free CME and MOC credit

How do you prevent hyponatremia in a patient with arginine vasopressin deficiency on chronic desmopressin?

2 Answers

Mednet MemberInvited Expert
Endocrinology · Harvard Medical School

Adequate instruction is very important in order to minimize the risk of hyponatremia in patients with AVP-D (central DI). Patients need to understand that, rather than taking desmopressin on a fixed schedule, it is very important to allow the medication to wear off for at least 30 minutes once a day...

Is there any role for bisphosphonate or alternative bone-modifying agents use in SMM in the absence of other indications for its use?

1 Answers

Mednet MemberInvited Expert
Medical Oncology · Harvard Medical School

The short answer is no, unless the patient has an indication like osteoporosis. Bisphosphonates have been evaluated in smoldering multiple myeloma in studies performed over 10 years ago. Treatment with pamidronate (D’Arena et al., 2011) or zoledronic acid (Musto et al., 2008) did not affect the time...

Do you recommend structured Tai Chi for patients with osteopenia and osteoporosis?

2 Answers

Mednet MemberInvited Expert
Rheumatology · U of AZ Phoenix Dept of Orthopaedics

While I am not an expert, I am very supportive of Tai Chi or similar disciplines that work to improve balance. I have read some well done clinical trials that show improved balance. I live in a community (Phoenix) with lots of active retired people. Nearly every community has a Tai Chi or balance cl...

What therapies do you offer patients who have osteoporosis and CKD and have had adverse reactions to several oral bisphosphonate therapies and denosumab?

1 Answers

Mednet MemberInvited Expert
Rheumatology · Icahn School of Medicine at Mount Sinai

Without further details as to the severity of CKD, the severity of the osteoporosis, and the specific intolerance issues with denosumab (and/or BPs), this is a very difficult question to provide specific advice. Some general comments can be offered: CKD stage 4-5 is essentially without fracture data...

How do you manage an implanted insulin pump or continuous glucose monitoring device during radiation?

6
2 Answers

Mednet MemberInvited Expert
Radiation Oncology · Virginia Commonwealth University Medical Center

We do not have an official written policy yet, but honestly, we probably should develop one, since these devices are becoming more prevalent. For CGMs, we ask the patient to place the device far from the treatment site while under treatment and to verify function with finger stick glucose measuremen...

In patients with a history of retinal vein occlusion, how should the risk of recurrent thromboembolic events influence the selection of osteoporosis therapies?

3
2 Answers

Mednet Member
Endocrinology · William Jennings Bryan Dorn Department Of Veterans Affairs Medical Center

The FDA-approved prescribing information for raloxifene explicitly lists retinal vein thrombosis alongside deep vein thrombosis and pulmonary embolism as contraindications.

Can you use bisphosphonates in a patient with osteoporosis who has had prior avascular necrosis of TMJ due to steroid use?

1
1 Answers

Mednet MemberInvited Expert
Rheumatology · Penn Medicine

Due to the rarity of medication-related osteonecrosis of the jaw (MRONJ) and significantly high fracture risk from osteoporosis, prior history of osteonecrosis is not considered an absolute contraindication for bisphosphonate use. The clinical picture is important in weighing this decision. If the p...